These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 19596662)

  • 41. [Use of a lipid lymphographic agent, lipiodol, as a carrier of high molecular weight antitumor agent, smancs, for hepatocellular carcinoma].
    Konno T; Maeda H; Yokoyama I; Iwai K; Ogata K; Tashiro S; Uemura K; Mochinaga M; Watanabe E; Nakakuma K; Morinaga T; Miyauchi Y
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):2005-15. PubMed ID: 6307179
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Histological effect of SMANCS/LPD therapy in renal cell carcinoma].
    Suzuki T; Kobayashi M; Nakamura T; Takahashi O; Imai K; Yamanaka H; Suzuki K; Konno T; Maeda H
    Nihon Gan Chiryo Gakkai Shi; 1987 Oct; 22(9):2210-7. PubMed ID: 2833546
    [No Abstract]   [Full Text] [Related]  

  • 43. [Combination of transcatheter arterial infusion of SMANCS and embolization on hepatocellular carcinoma].
    Hirashima N; Kumada K; Sakakibara K; Hirai T; Nemoto S; Matsuura H; Itazu I; Nojiri O; Kano H
    Gan To Kagaku Ryoho; 1995 Sep; 22(10):1411-5. PubMed ID: 7668880
    [No Abstract]   [Full Text] [Related]  

  • 44. [Evaluation of hepatic artery occlusion after intra-arterial infusion of SMANCS in patients with hepatocellular carcinoma].
    Sakaguchi T; Yoshimatsu S; Sagara K; Yamashita Y; Takahashi M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Oct; 58(12):700-4. PubMed ID: 9844406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experience with intraarterial infusion of styrene maleic acid neocarzinostatin (SMANCS)-lipiodol in pancreatic cancer.
    Yoshida H; Onda M; Tajiri T; Uchida E; Arima Y; Mamada Y; Yamamoto K; Kaneko M; Terada Y; Kumazaki T
    Hepatogastroenterology; 1999; 46(28):2612-5. PubMed ID: 10522050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Targeted chemotherapy of hepatocellular carcinoma using Lipiodol as a carrier].
    Konno T; Oda T; Nagamitsu A; Tabaru K; Yamashita R; Kai Y
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1392-9. PubMed ID: 8854762
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comparative studies on the antitumor activities and side effects of segmental SMANCS/Lip-TAE with segmental SMANCS/Lip-TAI for hepatocellular carcinoma].
    Matoba M; Okimura T; Yamamoto I
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():73-9. PubMed ID: 9512692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A case of long-term survival with TAE resistant multiple recurrence HCC successfully treated by hepatic resection].
    Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Hiramatsu N; Hayashi N; Monden M
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1717-21. PubMed ID: 14619502
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Good response in case of hepatocellular carcinoma; a case report of interdisciplinary local therapy].
    Niinobu T; Shibata T; Shibata N; Takada T; Kitada M; Tsukahara Y; Hata S; Ikeda K; Hayashida H; Ogawa M; Hayashi N; Akazawa K; Takami M
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1379-81. PubMed ID: 9703833
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS.
    Maeda H; Sawa T; Konno T
    J Control Release; 2001 Jul; 74(1-3):47-61. PubMed ID: 11489482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successful arterial administration therapy of SMANCS for liver metastasis of malignant insulinoma.
    Igarashi H; Ito T; Ogoshi K; Kuroiwa T; Koyanagi S; Arita Y; Sumii T; Nawata H
    Pancreas; 1999 Aug; 19(2):207-10. PubMed ID: 10438170
    [No Abstract]   [Full Text] [Related]  

  • 52. [Treatment of carcinomatous effusion with oily anticancer agents dissolved in lipiodol].
    Kimura M; Konno T; Oda T; Yamashita R
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1579-82. PubMed ID: 2167635
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A case of recurrent multiple HCC after surgical resection showing regression by two TAEs using 5-FU and zinostatin stimalamer].
    Takiya S; Sawada T; Takahashi K; Tagaya T; Fukuzawa Y; Kato K; Murata K; Ikeda H
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1205-8. PubMed ID: 8751812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Early phase II study of YM 881 (zinostatin stimalamer) by intravenous injection. Research group for intravenous YM 881].
    Saito T; Nakao I; Wakui A; Niitani H; Kurihara M; Konno T; Tsukagoshi S; Maeda H
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1319-23. PubMed ID: 1829883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor-targeted chemotherapy with lipid contrast medium and macromolecular anticancer drug (SMANCS) for renal cell carcinoma.
    Kobayashi M; Imai K; Sugihara S; Maeda H; Konno T; Yamanaka H
    Urology; 1991 Mar; 37(3):288-94. PubMed ID: 1848030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors and mechanism of "EPR" effect and the enhanced antitumor effects of macromolecular drugs including SMANCS.
    Fang J; Sawa T; Maeda H
    Adv Exp Med Biol; 2003; 519():29-49. PubMed ID: 12675206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transcatheter arterial embolization with zinostatin stimalamer for hepatocellular carcinoma.
    Okusaka T; Okada S; Ueno H; Ikeda M; Iwata R; Furukawa H; Takayasu K; Moriyama N; Sato T; Sato K
    Oncology; 2002; 62(3):228-33. PubMed ID: 12065870
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A preliminary report on the treatment of pleural carcinomatosis with SMANCS].
    Kimura M; Kaneda H; Kume S; Matsushita H; Inoue M; Kai M; Takeuchi H; Uemura K
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):1023-5. PubMed ID: 11478133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
    Maeda H; Bharate GY; Daruwalla J
    Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.
    Maeda H
    Adv Drug Deliv Rev; 2001 Mar; 46(1-3):169-85. PubMed ID: 11259839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.